USFDA Issues Warning Letter To Lupin

The United States Food and Drug Administration (USFDA) carried out the inspection of the company's Vizag API manufacturing facility between January 13, 2020 and January 17, 2020.

Updated On: 20 Feb 2020 | 10:25 AM IST

USFDA issued a warning letter to Lupin for violation of current good manufacturing practice norms at two of its manufacturing facilities in Goa and Indore

Updated On: 16 Nov 2017 | 7:39 PM IST